NPI registry status
Active
2026 NPPES data Procedural Dermatology Physician NPI 1770587735 MD
Verify on CMS → David Allyn, MD
Procedural Dermatology Physician in Clermont, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 691 in Procedural Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 573 beneficiaries · Procedural Dermatology Physician avg: 726
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$175.03
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
David Allyn, MD filed 1,626 Medicare Part D claims in 2024 as a Procedural Dermatology Physician in Clermont, Florida, prescribing 96% generic.
- 2K
- Part D claims, 2024
- 96%
- generic prescribing
- $175.03
- industry payments (Sunshine Act)
- ≥81st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about David Allyn, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1770587735), first enumerated 06/08/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,626 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$175.03 in reported industry payments (7 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not David Allyn, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1770587735 · Procedural Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1770587735
- ENUM-LEGACY 2005
- TAX-NARROW 691
- RX-MID 1,626
- BOOK-THIN 75 in Florida
- PHOTO-ENUM Scott Glazer · 2005
David Allyn, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,626 ≥ 81st percentile 81% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
David Allyn, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Allyn, MD?
Quality data not reportedPrimary specialty
Procedural Dermatology Physician
Medicare Part D claims
1,626 124% vs specialty avg
Specialty distribution in Florida
How Procedural Dermatology Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Procedural Dermatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1770587735 |
|---|---|
| Specialty | Procedural Dermatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/08/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for David Allyn, MD. Source: openpaymentsdata.cms.gov.
Total received
$175
Largest payer
REVANCE THERAPEUTICS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to David Allyn, MD. To verify David Allyn, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
David Allyn, MD - brand share 4.0%
Procedural Dermatology Physician average
4% brand-name claims vs 96% generic, on 1,626 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,626
Total Claims
$365K
Total Drug Cost
573
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,758.233
- Total Day Supply
- 38,123
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $318K
- Generic Drug Cost
- $47K
- Antibiotic Claims
- 310
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 1.49
- Gender Split
- 46% female / 54% male
- Age Distribution
- <65: 48, 65-74: 223, 75-84: 234, 85+: 68
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What David Allyn, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Triamcinolone Acet…
Triamcinolone Acetonide
321 claims
- Mupirocin
Mupirocin
313 claims
- Doxycycline Hyclate
Doxycycline Hyclate
279 claims
- Betamethasone Dipr…
Betamethasone Diprop Augmented
157 claims
- Clobetasol Propion… 98
Clobetasol Propionate
98 claims
- Clindamycin Phosph… 52
Clindamycin Phosphate
52 claims
- Ketoconazole 42
Ketoconazole
42 claims
- Fluocinolone Aceto… 41
Fluocinolone Acetonide
41 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 321 |
| Mupirocin | 313 |
| Doxycycline Hyclate | 279 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 157 |
| Clobetasol Propionate | 98 |
| Clindamycin Phosphate | 52 |
| Ketoconazole | 42 |
| Fluocinolone Acetonide | 41 |
| Gentamicin Sulfate | 41 |
| Betamethasone Dipropionate | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Procedural Dermatology Physician Overview
How David Allyn, MD fits within the Procedural Dermatology Physician landscape nationally.
691
Procedural Dermatology Physician Providers in US
49
States with Procedural Dermatology Physician
726
Avg Claims per Provider
David Allyn, MD's 1,626 claims are above the specialty average of 726.
Nationwide Procedural Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Allyn, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Procedural Dermatology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Allyn.
One of 75 Procedural Dermatology Physician providers enrolled in Florida, 5 are shown here.
Dr. Nadine Acri
MD
Melbourne, FL
Dr. Thomas Balshi
M.D.
Delray Beach, FL
Dr. Keith Benbenisty
M.D.
Fort Myers, FL
Dr. Abram Berens
M.D.
Plantation, FL
Dr. Juan Bravo
MD, CWS
Lakeland, FL
Compare Procedural Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is David Allyn, MD's specialty? ▼
David Allyn, MD specializes in Procedural Dermatology Physician and practices in Clermont, Florida. Credentials: MD.
How much does David Allyn, MD prescribe under Medicare Part D? ▼
In 2024, David Allyn, MD wrote 1,626 Medicare Part D claims totaling $365K in drug costs for 573 beneficiaries.
Where is David Allyn, MD located? ▼
David Allyn, MD is located at 210 N HIGHWAY 27 STE 1, Clermont, FL, 34711. Phone: (352) 243-2544.
What is David Allyn, MD's NPI number? ▼
David Allyn, MD's National Provider Identifier (NPI) is 1770587735, issued on 06/08/2005.
Does David Allyn, MD prescribe more brand-name or generic drugs? ▼
David Allyn, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $318K in brand drug costs.
How many Procedural Dermatology Physician providers are there in the US? ▼
There are 691 Procedural Dermatology Physician providers across 49 states in the US. The average Procedural Dermatology Physician provider writes 726 Medicare Part D claims per year.
What drugs does David Allyn, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, David Allyn, MD's most frequently prescribed drugs include Triamcinolone Acetonide, Mupirocin, Doxycycline Hyclate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Allyn, MD accept Medicare? ▼
David Allyn, MD appears in CMS Medicare data with 1,626 Part D claims and 573 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Allyn, MD's credentials? ▼
David Allyn, MD's NPI is 1770587735 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.